Asia Pacific Sepsis Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, Microarrays}, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

No. of Pages: 192    |    Report Code: BMIRE00025658    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Sepsis Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Sepsis Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Sepsis Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 High sepsis mortality rates
  • 5.1.2 Need for rapid diagnosis
5.2 Market Opportunities
  • 5.2.1 Development of POC diagnostics
  • 5.2.2 Use of biomarkers
5.3 Future Trends
  • 5.3.1 Demand in critical care settings
  • 5.3.2 Government initiatives for better diagnostics
5.4 Impact of Drivers and Restraints

6. Asia Pacific Sepsis Diagnostics Market Regional Analysis

6.1 Asia Pacific Sepsis Diagnostics Market Overview
6.2 Asia Pacific Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Sepsis Diagnostics Market Forecast Analysis

7. Asia Pacific Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments
  • 7.1.1 Overview
  • 7.1.2 Instruments: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents and Assays
  • 7.2.1 Overview
  • 7.2.2 Reagents and Assays: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Blood Culture Media
  • 7.3.1 Overview
  • 7.3.2 Blood Culture Media: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Software
  • 7.4.1 Overview
  • 7.4.2 Software: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics
  • 8.1.1 Overview
  • 8.1.2 Molecular Diagnostics : Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Sepsis Diagnostics Market Analysis – by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9. Asia Pacific Sepsis Diagnostics Market – Asia-Pacific Analysis

9.1 Asia-Pacific
  • 9.1.1 Asia Pacific Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.1.1.1 Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 China: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 China: Asia Pacific Sepsis Diagnostics Market Breakdown, by Product
    • 9.1.1.1.2 China: Asia Pacific Sepsis Diagnostics Market Breakdown, by Technology
    • 9.1.1.1.3 China: Asia Pacific Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
  • 9.1.1.2 India: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.2.1 India: Asia Pacific Sepsis Diagnostics Market Breakdown, by Product
    • 9.1.1.2.2 India: Asia Pacific Sepsis Diagnostics Market Breakdown, by Technology
    • 9.1.1.2.3 India: Asia Pacific Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
  • 9.1.1.3 Japan: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.3.1 Japan: Asia Pacific Sepsis Diagnostics Market Breakdown, by Product
    • 9.1.1.3.2 Japan: Asia Pacific Sepsis Diagnostics Market Breakdown, by Technology
    • 9.1.1.3.3 Japan: Asia Pacific Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
  • 9.1.1.4 Australia: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.4.1 Australia: Asia Pacific Sepsis Diagnostics Market Breakdown, by Product
    • 9.1.1.4.2 Australia: Asia Pacific Sepsis Diagnostics Market Breakdown, by Technology
    • 9.1.1.4.3 Australia: Asia Pacific Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
  • 9.1.1.5 Rest of Asia-Pacific : Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Sepsis Diagnostics Market Breakdown, by Product
    • 9.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Sepsis Diagnostics Market Breakdown, by Technology
    • 9.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Asia Pacific Sepsis Diagnostics Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Abbott
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 BD
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 bioMerieux SA
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Danaher (Beckman Coulter)
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 F. HOFFMANN-LA ROCHE LTD.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Immunexpress Inc.
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Luminex Corporation
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 T2 Biosystems, Inc.
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 THERMO FISHER SCIENTIFIC INC.
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - Asia Pacific Sepsis Diagnostics Market

  1. Abbott
  2. BD
  3. bioMerieux SA
  4. Danaher (Beckman Coulter)
  5. F. HOFFMANN-LA ROCHE LTD.
  6. Immunexpress Inc.
  7. Luminex Corporation
  8. T2 Biosystems, Inc.
  9. THERMO FISHER SCIENTIFIC INC.
asia-pacific-sepsis-diagnostics-market